HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

eptifibatide (Integrilin)

used in clinical studies as a platelet glycoprotein IIB/IIIA antagonist
Also Known As:
Integrilin; Cor brand of eptifibatide; Essex brand of eptifibatide; GlaxoSmithKline UK brand of eptifibatide; Integrelin; Key brand of eptifibatide; Pfizer brand of eptifibatide; epifibatide; epifibratide
Networked: 439 relevant articles (52 outcomes, 158 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Harrington, Robert A: 31 articles (10/2013 - 01/2002)
2. Califf, Robert M: 22 articles (04/2014 - 01/2002)
3. Gibson, C Michael: 21 articles (04/2014 - 04/2003)
4. Califf, R M: 20 articles (07/2002 - 01/2000)
5. Armstrong, Paul W: 19 articles (04/2014 - 01/2002)
6. Harrington, R A: 19 articles (07/2002 - 01/2000)
7. Topol, E J: 19 articles (02/2002 - 01/2000)
8. Giugliano, Robert P: 18 articles (04/2014 - 04/2003)
9. Newby, L Kristin: 18 articles (04/2014 - 06/2003)
10. Lincoff, A M: 14 articles (07/2002 - 02/2000)

Related Diseases

1. Acute Coronary Syndrome
2. Myocardial Infarction
3. Unstable Angina
4. Hemorrhage
5. Ischemia

Related Drugs and Biologics

1. eptifibatide (Integrilin)
2. Glycoproteins (Glycoprotein)
3. tirofiban (Aggrastat)
4. Enoxaparin (Lovenox)
5. Heparin (Liquaemin)
6. abciximab (ReoPro)
7. Platelet Membrane Glycoprotein IIb
8. Aspirin (Acetylsalicylic Acid)
9. clopidogrel (Plavix)
10. tenecteplase

Related Therapies and Procedures

1. Stents
2. Drug-Eluting Stents
3. Coronary Artery Bypass (Coronary Artery Bypass Surgery)
4. Thrombolytic Therapy
5. Resuscitation